Phathom Pharmaceuticals (NASDAQ:PHAT) reported quarterly losses of $(1.00) per share. This is a 56.25 percent decrease over losses of $(0.64) per share from the same period last year.
BTIG Upgrades Invitation Homes to Buy, Announces $50 Price Target
BTIG analyst James Sullivan upgrades Invitation Homes (NYSE:INVH) from Neutral to Buy and announces $50 price target.